Hipertensión maligna y SHUa

REFERENCIA: 1. Cavero, Teresa, et al. “Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.” Kidney International (2019).

Diagnóstico diferencial: KDIGO

REFERENCIAS: 1. Goodship TH, Cook HT, Fakhouri F, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2017;91(3):539-51. 2. Campistol JM, et al. Nefrología. 2015;35(5):421-47.

SHUa 2ario

REFERENCIA: Cavero, Teresa, et al. "Eculizumab in secondary atypical haemolytic uraemic syndrome." Nephrology Dialysis Transplantation 32.3 (2017): 466-474.